How to apply Randomization and Trial Supply Management benefits to all clinical trial phases
Randomization and Trial Supply Management (RTSM), also known as Interactive Response Technology (IRT), solutions are extensively used on Phase II/III studies to manage enrolment, treatment allocations and supplies inventory management. To date there have been barriers to adoption on early phase proof of concept trials (IIa) and Peri/Post-Approval (IIIb/IV) studies due to their unique challenges. This webinar will explore the specific challenges of each phase of trials and examine new approaches to implementing technology-enabled services for RTSM that address those needs.
- Understand the unique challenges of each phase of clinical development
- Explore RTSM capabilities and their applicability to each phase
- Learn how RTSM services can be tailored to meet the specific needs of each phase
Who Should Attend:
Directors/Managers of Clinical Operations and Clinical Supplies from pharmaceutical and biotechnology companies
Darren Wells, Product Director, Randomization & Trial Supply Management (RTSM), PAREXEL
Darren works with clients to understand their RTSM requirements and defines the strategy, priorities and roadmap to meet PAREXEL Informatics’ business strategy and exceed client expectations. Darren has over 7 years’ experience in eClinical technology, and an extensive background in leading strategy and financial control.
Peter Woods, Associate Director, RTSM Production Services, PAREXEL
Peter has worked for PAREXEL Informatics since 2003. During that time Peter has been a member of project teams which have delivered a number of service enhancements to the ClinPhone RTSM product, including drug accountability and web reporting.
Registration is complimentary. A valid business Email address is required to attend